Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Breaking News

Ryan Braun Plans To Admit Using Performance-Enhancing Drugs

Ryan Braun, the first Jewish baseball player to win the Most Valuable Player award in decades, reportedly plans to admit using performing enhancing drugs.

The so-called Hebrew Hammer will also apologize to teammates and baseball officials for his long string of lies about doping, USA Today reported.

Braun, the embattled Milwaukee Brewers left fielder, plans to admit using PED’s during his MVP 2011 season, friends told the paper. He is expected to explain the reasons why he used the drugs and to apologize, something he has so far refused to do.

He has spoken proudly about his Jewish heritage and was named to the Forward 50 after the now-tainted 2011 season.

Braun last month agreed to a ban for the rest of the 2013 season for a drug violation.

Braun decided not to challenge the punishment that abruptly ended his 2013 season on Monday after MLB investigators probing the alleged dispersal of performance enhancing drugs by a now-shut Florida anti-aging clinic presented their evidence to him.

No explanation or detail of Braun’s doping violation have yet been released, but several other players, including New York Yankees superstar Alex Rodriguez, have been implicated in the Biogenesis scandal.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse..

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

—  Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.